Category: CBSA News

January 8th marks the first day of Colorado’s 2020 legislative session, but CBSA has already been hard at work advocating on behalf of our members and the patients they serve. This session, we will co...

This week Congress voted to pass a full and permanent repeal of the medical device excise tax as part of legislation to fund the federal government through the rest of the current fiscal year. This is...

DENVER – Colorado’s life sciences ecosystem raised $750 million in 2019, with funds from federal and state grants, successful financing rounds and acquisitions. The record-breaking acquisition of Boul...

Weekly Policy Update: CBSA Comments on 2020 Drug Price Transparency Draft Legislation  On Monday, CBSA sent a comment letter to Rep. Dominique Jackson and Rep. Dylan Roberts outlining our comment...

Policy Update: CBSA Submits Recommendations to Improve the SBIR/STTR Program  Earlier this year, CBSA partnered with Fitzsimons Innovation Community, Gates Biomanufacturing Facility, and Sharklet...

Brand update delivers results for CBSA and Colorado’s life sciences ecosystem Denver – Colorado BioScience Association (CBSA) recognizes two Denver-area firms, Primavera Group and Watermark, for gener...

Policy Update: CBSA Presents Sen. Cory Gardner with ALSIC 2019 Champion of Health Care Innovation Award CBSA was proud to present Senator Cory Gardner with the American Life Sciences Innovation Counci...

CBSA celebrated the life of Adam Rubenstein at the 16th Annual Awards Dinner.

Policy Update: Colorado Votes Colorado voters decided on two major ballot measures on Election Day 2019. Proposition DD asked voters to legalize sports betting in Colorado and create a 10 percent tax...